Could your own blood heal a stubborn eye ulcer?
NCT ID NCT03653650
First seen May 12, 2026 · Last updated May 19, 2026 · Updated 2 times
Summary
This study tests a treatment for people with a persistent corneal epithelial defect (PED) — a sore on the eye that won't heal with standard drops. The treatment uses a substance made from the patient's own blood, called platelet-rich plasma (PRP), which may help replace missing healing factors in the tears. About 54 participants will be randomly assigned to receive either PRP with a contact lens, standard lubricant with a contact lens, or an eye patch with ointment. The goal is to see which approach heals the ulcer fastest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT EPITHELIAL DEFECT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Departamento de Oftalmologia, Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
RECRUITINGMonterrey, Nuevo León, 64460, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.